Condition: NSCLC Stage II · NSCLC, Stage III · Sponsor: University of Utah
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.
This description comes directly from the study's public registry record.
Thomas Varghese, MD, MS, MBA, FACS · 801-581-5311 · thomas.varghese@hsc.utah.edu
Cornelia Ulrich, MS, PhD · 801-213-5716 · neli.ulrich@hci.utah.edu
Always discuss trial participation with your own doctor first.
| University of Texas Medical Branch at Galveston | Galveston, Texas, United States | Recruiting |
| Huntsman Cancer Institute | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06945484